Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)

  • Giulia Capelli
  • , Giovanni Capelli
  • , Irene De Simone
  • , Idor De Simone
  • , Gaya Spolverato
  • , Michela Cinquini
  • , Ivan Moschetti
  • , Sara Lonardi
  • , Gianluca Masi
  • , Chiara Carlomagno
  • , Domenico Corsi
  • , Domenico Cristiano Corsi
  • , Gabriele Luppi
  • , Sergio Guido Luppi
  • , Maria Antonietta Gambacorta
  • , Francesca Valvo
  • , Renato Cannizzaro
  • , Federica Grillo
  • , Brunella Barbaro
  • , Angelo Restivo
  • Attilio Restivo, Marco Messina, Alessandro Pastorino, Carlo Aschele, Salvatore Pucciarelli
  • University of Padua
  • IRCCS Istituto di ricerche farmacologiche Mario Negri - Milano, Bergamo, Ranica
  • IRCCS Istituto Oncologico Veneto - Padova
  • University of Pisa
  • University of Naples Federico II
  • Ospedale San Giovanni Calibita Fatebenefratelli
  • University of Modena and Reggio Emilia
  • National Center for Oncological Hadrontherapy (CNAO)
  • IRCCS Centro di Riferimento Oncologico - Aviano PN
  • San Martino Hospital Genoa
  • University of Cagliari
  • San Raffaele-Giglio Hospital
  • Sant'Andrea Hospital

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Background: The standard approach for locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision (TME). After nCRT 20% of patients achieve a clinical complete response (pCR) and could be treated with a non-operative management (NOM). Methods: The panel of the Italian Association of Medical Oncology (AIOM) Guidelines on rectal cancer applied the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach addressing the following question: Should NOM vs. TME be used for patients with rectal cancer with clinical complete response after nCRT? Five outcomes were identified: disease-free survival (DFS), mortality, local recurrence, colostomy rate, and functional outcomes. Results: Nine studies were included in the analysis. A higher risk of disease recurrence was observed in the NOM group compared to the TME group (RR = 1.69, 95% CI 1.08, 2.64) on the other hand, we observed a slightly positive but not significant effect on mortality of NOM (RR = 0.82, 95% CI 0.46, 1.45). Patients in the NOM group were more likely to experience local recurrence (RR = 5.37, 95% CI 2.56, 11.27) and patients in the TME group were more likely to have a permanent colostomy (RR = 0.15, 95% CI 0.08, 0.29). Only one study evaluated functional outcomes. The overall certainty of evidence was rated as very low. Conclusions: NOM was found to correlate with a higher risk of local recurrence which did not translate in worse OS and a lower colostomy rate. Due to the paucity of evidences, no recommendations are possible. NOM remains an experimental treatment; thus, patients managed with NOM should be enrolled in clinical trials with a dedicated follow-up schedule.
Lingua originaleInglese
pagine (da-a)2150-2159
Numero di pagine10
RivistaJournal of Gastrointestinal Surgery
Volume24
DOI
Stato di pubblicazionePubblicato - 2020

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

  1. SDG 3 - Salute e benessere
    SDG 3 Salute e benessere

Keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Chemoradiotherapy
  • Disease-Free Survival
  • GRADE
  • GRADE Approach
  • Humans
  • Italy
  • Medical Oncology
  • Metanalysis
  • Neoadjuvant Therapy
  • Neoadjuvant chemotherapy
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Rectal Neoplasms
  • Rectal cancer
  • Surgery
  • Treatment Outcome
  • Writing

Fingerprint

Entra nei temi di ricerca di 'Non-Operative Management Versus Total Mesorectal Excision for Locally Advanced Rectal Cancer with Clinical Complete Response After Neoadjuvant Chemoradiotherapy: a GRADE Approach by the Rectal Cancer Guidelines Writing Group of the Italian Association of Medical Oncology (AIOM)'. Insieme formano una fingerprint unica.

Cita questo